Rifamycin in Minimal Hepatic Encephalopathy

计划入组 30 人 · 首次发布于 2019 年 9 月 9 日

A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

计划入组 414 人 · 首次发布于 2022 年 10 月 12 日

Safety and Therapeutic Efficacy of Phosphate Enema (Kleen Enema) in Patients Undergoing Sigmoidoscopy

计划入组 40 人 · 首次发布于 2015 年 3 月 12 日

Rifamycin(Aemcolo)

C₃₇H₄₇NO₁₂

Kuijiekang Enema

Manpenkang Enema

Shanghai Xiao Fang Pharmaceutical Co.,Ltd.

NEMA Research, Inc.

NEMA RESEARCH INC

United States

Cosmo Completes Phase II Enrollment for Novel Rifamycin Enema in Distal Ulcerative Colitis

Discovery of Arr-X: A Novel, Highly Efficient Rifamycin-Inactivating Enzyme Family Reveals New Antibiotic Resistance Mechanisms Across Mycobacteria

Whole-genome sequencing maps rpoB mutations that predict rifabutin susceptibility in multidrug-resistant tuberculosis